Sarepta Therapeutics

YTD

ALL

Trade Sarepta Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About SRPT

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

CEO

Douglas S. Ingram

CEODouglas S. Ingram

Employees

1,372

Employees1,372

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

1980

Founded1980

Employees

1,372

Employees1,372

SRPT Key Statistics

Market cap

1.71B

Market cap1.71B

Price-Earnings ratio

-22.92

Price-Earnings ratio-22.92

Dividend yield

—

Dividend yield—

Average volume

5.70M

Average volume5.70M

High today

$18.27

High today$18.27

Low today

$17.23

Low today$17.23

Open price

$17.47

Open price$17.47

Volume

5.13M

Volume5.13M

52 Week high

$138.81

52 Week high$138.81

52 Week low

$10.42

52 Week low$10.42

SRPT News

Simply Wall St 1d

Why Sarepta Therapeutics Is Down 7.1% After ELEVIDYS Gene Therapy Disclosure Probe Announced And What’s Next

An investigation was announced for long-term shareholders of Sarepta Therapeutics following allegations of securities law violations related to disclosures abou...

TipRanks 6d

Sarepta price target raised to $15 from $12 at Leerink

Leerink analyst Joseph Schwartz raised the firm’s price target on Sarepta (SRPT) to $15 from $12 and keeps a Market Perform rating on the shares. The firm notes...

Analyst ratings

61%

of 28 ratings

Buy

21.4%

Hold

60.7%

Sell

17.9%

People also own

Based on the portfolios of people who own SRPT. This list is generated using Robinhood data, and it’s not a recommendation.